Identification of Immunomodulatory Drugs That Inhibit Multiple Inflammasomes and Impair SARS-CoV-2 Infection

The authors performed a high-throughput screening using a 2560 small-molecule compound library and identified FDA-approved drugs that functioned as pan-inflammasome inhibitors.